Skip to contentR
Rockwell Medical, Inc.
R
RMTIRockwell Medical, Inc. Q3 2019 · 10-Q
Revenue$15.41M$15.41M−7.6% vs Q3 2018 Net Income-$7.86M-$7.86MN/M vs Q3 2018 EPS Diluted-$120.00-$120.00N/M vs Q3 2018 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rockwell Medical, Inc. · CIK 1041024 · Engraved from SEC EDGAR
Operating Cash Flowderived-$6,175,583N/M Margins · derivedGross margin-0.1%−11.9 pt vs Q3 2018
Operating margin-51.5%−21.6 pt vs Q3 2018
Net margin-51.0%−21.2 pt vs Q3 2018
ended Sep 30, 2019 · filed Nov 12, 2019 · 43 d after period end